Evidence map›Paper›PMID 36478979›Full record

ArticleJAAD case reports2023

A case of Rowell syndrome with excellent improvement following anifrolumab.

Chelsea Shope, Laura Andrews, Melissa Cunningham, Jessica Connett

Abstract readCase Reports
In one paragraph

Article in JAAD case reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Rowell's syndrome.EULAR rheumatology open · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Chelsea ShopeCollege of Medicine, Medical University of South Carolina, Charleston, South Carolina.
Laura AndrewsCollege of Medicine, Medical University of South Carolina, Charleston, South Carolina.
Melissa CunninghamDepartment of Rheumatology, Medical University of South Carolina, Charleston, South Carolina.
Jessica ConnettDepartment of Dermatology & Dermatologic Surgery, Medical University of South Carolina, Charleston, South Carolina.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

anifrolumabBAFF, B cell-activating factorCLE, cutaneous lupus erythematosuscutaneous lupus erythematousDIF, direct immunofluorescenceDLE, discoid lupus erythematosusEM, erythema multiformeHAART, highly active antiretroviral therapyHCQ, hydroxychloroquineHIV, human immunodeficiency virusIFNAR1, interferon- α receptor 1IL, intralesionalimmunotherapyIVIg, intravenous immunoglobulinLE, lupus erythematosusMMF, mycophenolate mofetilPIPA, post inflammatory pigment alterationRowell syndromeRS, Rowell syndromeSCLE, subacute cutaneous lupus erythematosusSLE, systemic lupus erythematous

Identifiers

PMID36478979
PMCPMC9720243

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.